{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:15:15Z","timestamp":1780528515289,"version":"3.54.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Recently, cilostazol, a phosphodiesterase III inhibitor, has been described as alternative medical treatment for canine bradyarrhythmia in cases for which pacemaker implantation was not indicated or available. In this retrospective study, we investigated the use and efficacy of cilostazol in dogs with bradyarrhythmia in Japan. Dogs that had been brought to the Tokyo University of Agriculture and Technology Animal Medical Center and 23 veterinary hospitals in Japan and been treated with cilostazol initially as the only therapeutic strategy for bradyarrhythmia between January 2010 and August 2021 were included in this study. Survival analyses were performed using Cox proportional hazards analysis, the log-rank test, and the generalized Wilcoxon test to evaluate the efficacy of cilostazol. Fifty-nine privately owned dogs were included in this study. In the survival time analysis, the risk of death was significantly lower and the survival rate was higher in cases in which cilostazol was administered at 10 mg\/kg or more per dose. A third-degree atrioventricular block also significantly increased the risk of death and was associated with a lower survival rate. However, in some patients with a third-degree atrioventricular block, there was an increase in the ventricular rate and improvement in clinical symptoms without disappearance or decrease of the atrioventricular block. This study had several important findings that have not previously been reported concerning the use of cilostazol for canine bradyarrhythmia, including the appropriate dose in a clinical setting and the efficacy and prognosis according to the type of bradyarrhythmia.<\/jats:p>","DOI":"10.3389\/fvets.2022.954295","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T15:47:46Z","timestamp":1660664866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of cilostazol in canine bradyarrhythmia"],"prefix":"10.3389","volume":"9","author":[{"given":"Takahiro","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritada","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","volume-title":"Electrocardiography of the Dog and Cat: Diagnosis of Arrhythmias","author":"Santilli","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1292\/jvms.65.1131","article-title":"Implantation of permanent transvenous endocardial pacemaker in a dog with atrioventricular block","volume":"65","author":"Kobayashi","year":"2003","journal-title":"J Vet Med Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.12935\/jvma1951.43.447","article-title":"Three cases of sinus bradycardia in dogs","volume":"43","author":"Machida","year":"1990","journal-title":"J Jpn Vet Med Assoc."},{"key":"B4","first-page":"143","article-title":"A case of sick sinus syndrome in german shepherd dog","volume":"11","author":"Shibasaki","year":"2001","journal-title":"J Anim Clin Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.22456\/1679-9216.85851","article-title":"Pacemaker implant in a dog with sick sinus syndrome","volume":"45","author":"Alexio","year":"2017","journal-title":"Acta Scientiae Veterinariae."},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jvc.2016.04.004","article-title":"Outcome and survival in canine sick sinus syndrome and sinus node dysfunction: 93 cases (2002-2014)","volume":"18","author":"Ward","year":"2016","journal-title":"J Vet Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jvc.2005.12.003","article-title":"Syncope secondary to transient atrioventricular block in a German shepherd dog with dilated cardiomyopathy and atrial fibrillation","volume":"8","author":"Billen","year":"2006","journal-title":"J Vet Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00005344-199804000-00010","article-title":"Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias","volume":"31","author":"Atarashi","year":"1998","journal-title":"J Cardiovasc Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1378\/chest.123.4.1161","article-title":"Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block","volume":"123","author":"Kodama","year":"2003","journal-title":"Chest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/147323000403200513","article-title":"Chronotropic effect of the antithrombotic agent cilostazol in a patient with sick sinus syndrome and syncope","volume":"32","author":"Moriya","year":"2004","journal-title":"J Int Med Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.2169\/internalmedicine.50.5228","article-title":"Recovery of advanced atrioventricular block by cilostazol","volume":"50","author":"Nimura","year":"2011","journal-title":"Intern Med."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.11276\/jsvc.46.43","article-title":"A canine case of sick sinus syndrome (Rubenstein-II) successfully treated with cilostazol: findings on monitoring with holter electrocardiography","author":"Komiya","year":"2013","journal-title":"Adv Anim Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1292\/jvms.17-0018","article-title":"Long term effects of cilostazol in a dog with sick sinus syndrome","volume":"79","author":"Kanno","year":"2017","journal-title":"J Vet Med Sci."},{"key":"B14","first-page":"77","volume-title":"Small Animal Internal Medicine.","author":"Nelson","year":"2019"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3390\/ani11061645","article-title":"Lorenz plot analysis in dogs with sinus rhythm and tachyarrhythmias","volume":"11","author":"Romito","year":"2021","journal-title":"Animals."},{"key":"B16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/vr.129.10.213","article-title":"Ambulatory electrocardiography in dogs","volume":"129","author":"Hall","year":"1991","journal-title":"Vet Rec."},{"key":"B17","first-page":"449","article-title":"Diagnosis and treatment of arrhythmias (dysrhythmias)","volume-title":"Small Animal Cardiovascular Medicine","author":"Kittleson","year":"1998"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2460\/javma.228.11.1710","article-title":"Signalment, clinical signs, and prognostic indicators associated with high-grade second- or third-degree atrioventricular block in dogs: 124 cases (January 1, 1997-December 31, 1997)","volume":"228","author":"Schrope","year":"2006","journal-title":"J Am Vet Med Assoc."},{"key":"B19","first-page":"123","article-title":"Syncope","volume-title":"Textbook of Veterinary Internal Medicine.","author":"Martin","year":"2017"},{"key":"B20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1939-1676.2007.0008.x","article-title":"Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease","volume":"22","author":"Borgarelli","year":"2008","journal-title":"J Vet Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1292\/jvms.18-0240","article-title":"Effects of cilostazol on the heart rate in healthy dogs","volume":"80","author":"Fukushima","year":"2018","journal-title":"J Vet Med Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jvim.15725","article-title":"ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs","volume":"34","author":"Reinero","year":"2020","journal-title":"J Vet Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jvc.2021.12.006","article-title":"Presumptive vagally-mediated atrial flutter in a dog","volume":"39","author":"Romito","year":"2022","journal-title":"J Vet Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jvc.2022.05.004","article-title":"Corrigendum to \u2018Presumptive vagally-mediated atrial flutter in a dog' [J Vet Cardiol (2022) 39, 46-50]","volume":"42","author":"Romito","year":"2022","journal-title":"J Vet Cardiol."},{"key":"B25","first-page":"719","volume-title":"Current Veterinary Therapy XIII.","author":"Rishniw","year":"2000"},{"key":"B26","first-page":"66","volume-title":"Bolton's Handbook of Canine and Feline Electrocardiography","author":"Edwards","year":"1987"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1201\/b15177","volume-title":"Cardiovascular Disease in Small Animal Medicine","author":"Ware","year":"2011"},{"key":"B28","first-page":"127","volume-title":"Essentials of Canine and Feline Electrography: Interpretation and Treatment","author":"Tilley","year":"1992"},{"key":"B29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1746-6148-9-132","article-title":"Molecular epidemiology of canine GM1 gangliosidosis in the Shiba Inu breed in Japan: relationship between regional prevalence and carrier frequency","volume":"9","author":"Uddin","year":"2013","journal-title":"BMC Vet Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jvc.2017.08.004","article-title":"Electrocardiographic, echocardiographic, and left atrial strain imaging features of a dog with atrial flutter and third-degree atrioventricular block","volume":"19","author":"Toaldo","year":"2017","journal-title":"J Vet Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/ani11030690","article-title":"Unusual presentation of aortic valve infective endocarditis in a dog: aorto-cavitary fistula, tricuspid valve endocarditis, and third-degree atrioventricular block","volume":"11","author":"Romito","year":"2021","journal-title":"Animals."},{"key":"B32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcpa.2007.05.006","article-title":"Complete atrioventricular block associated with lymphocytic myocarditis of the atrioventricular node in two young adult dogs","volume":"137","author":"Kaneshige","year":"2007","journal-title":"J Comp Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jcpa.2007.01.001","article-title":"A histological study of the cardiac conduction system in canine cases of mitral valve endocardiosis with complete atrioventricular block","volume":"136","author":"Kaneshige","year":"2007","journal-title":"J Comp Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5105\/jse.27.Suppl1_71","article-title":"The occurrence of serious ventricular arrhythmia in dogs and cats","volume":"27","author":"Uchino","year":"2007","journal-title":"J Arrhythm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J Vet Intern Med."},{"key":"B36","first-page":"977","article-title":"Usefulness of cilostazol for sinus node syndrome - about cases of manifestation of sinus node due to discontinuation of administration -","volume":"23","author":"Saito","year":"1995","journal-title":"Jpn Pharmacol Ther."},{"key":"B37","first-page":"1163","article-title":"General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: effect on the peripheral organs","volume":"35","author":"Shintani","year":"1985","journal-title":"Arzneimittelforschung."},{"key":"B38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3143\/geriatrics.36.561","article-title":"Cilostazol increased heart rate with improvement of activity of daily living in an elderly patient with sick sinus syndrome","volume":"36","author":"Yamashita","year":"1995","journal-title":"Nihon Ronen Igakkai Zasshi."},{"key":"B39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1527-3466.1993.tb00200.x","article-title":"Cilostazol","volume":"11","author":"Okuda","year":"1993","journal-title":"Cardiovasc Drug Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.11252\/dobutsurinshoigaku.26.29","article-title":"A case of situational syncope due to cough in a dog","volume":"26","author":"Fukushima","year":"2017","journal-title":"J Anim Clin Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.11276\/jsvc.50.15","article-title":"Two dogs with improved renal function after administration of cilostazol","volume":"50","author":"Fukushima","year":"2017","journal-title":"Adv Anim Cardiol."},{"key":"B42","first-page":"1133","article-title":"The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man","volume":"35","author":"Akiyama","year":"1985","journal-title":"Arzneimittelforschung."},{"key":"B43","first-page":"1268","article-title":"Toxicological studies on cilostazol (V). 13-Week subacute toxicity in dogs","volume":"16","author":"Nagano","year":"1985","journal-title":"Iyakuhin Kenkyu."},{"key":"B44","unstructured":"Rapid ventricular tachycardias associated with cilostazol use1402\n            GamssariF\n            MahmoodH\n            HoJS\n            VillarealRP\n            LiuB\n            RasekhA\n          12075874Tex Heart Inst J.292002"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.954295\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T15:48:02Z","timestamp":1660664882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.954295\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":44,"alternative-id":["10.3389\/fvets.2022.954295"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.954295","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"954295"}}